Loading clinical trials...
Loading clinical trials...
To evaluate the safety and efficacy of tigecycline in the treatment of subjects with selected serious infections caused by resistant gram-negative bacteria, eg, Acinetobacter baumannii, Enterobacter s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT06135350 · Gram Negative Pneumonia, Gram-Negative Bacterial Infections, and more
NCT06086626 · Gram-Negative Bacterial Infections
NCT04335539 · Gram-negative Bacterial Infections, Bloodstream Infections (BSI), and more
NCT04215991 · Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), and more
NCT02088840 · Complications of Organ Transplant Stem Cells, Gram-Negative Bacterial Infections
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions